ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neutrophils"

  • Abstract Number: 0110 • ACR Convergence 2023

    Neutrophil Extracellular Traps as Mediators of Antiphospholipid Antibody-Induced Trophoblast Dysfunction and Fetal Loss

    Christine Rysenga, Srilakshmi Yalavarthi, Wenying Liang, Claire Hoy, Cyrus Sarosh, Richard Lieberman, Yu Zuo and Jason Knight, University of Michigan, Ann Arbor, MI

    Background/Purpose: Antiphospholipid antibodies (aPL) induce obstetric complications associated with placental insufficiency by promoting trophoblast dysfunction and inflammation at the maternal-fetal interface. Neutrophils have been found…
  • Abstract Number: 1776 • ACR Convergence 2023

    Macrophage Migration Inhibitory Factor May Help Maintain Tight Junctions in the Gut by Enhancing Occludin Expression

    Shaghayegh Foroozan1 and Nigil Haroon2, 1University Health Network/University of Toronto, Toronto, ON, Canada, 2University of Toronto, University Health Network, Schroeder Arthritis Institute, Department of Medicine/Rheumatology, Toronto, ON, Canada

    Background/Purpose: Axial Spondyloarthritis (AxSpA) is a chronic inflammatory disease with multifactorial origins, primarily affecting the musculoskeletal system. Gut inflammation is seen in the majority of…
  • Abstract Number: 0112 • ACR Convergence 2023

    Molecular Stratification of Antiphospholipid Syndrome Patients Through Integrative Analysis of the Whole-blood RNA Transcriptome

    Amala Ambati1, Feiyang Ma1, Katarina Kmetova1, Sherwin Navaz1, Claire Hoy1, Cyrus Sarosh1, Ajay Tambralli1, Johann E. Gudjonsson1, J. Michelle Kahlenberg1, Jacqueline Madison1, Ali Duarte-Garcia2, Jason Knight1 and Yu Zuo1, 1University of Michigan, Ann Arbor, MI, 2Mayo Clinic, Rochester, MN

    Background/Purpose: Antiphospholipid syndrome (APS) is an acquired thrombo-inflammatory disease associated with diverse clinical manifestations in the setting of persistent antiphospholipid antibodies (aPL). Early diagnosis and…
  • Abstract Number: 1781 • ACR Convergence 2023

    TNF Induces Neutrophil Elastase/Gasdermin D-mediated Neutrophil Extracellular Traps in Axial Spondyloarthritis

    Yehao Li and Xiang Peng, Department of Rheumatology and Immunology, The Sixth Affiliated Hospital of Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, China

    Background/Purpose: Emerging studies have shown that neutrophil extracellular traps (NETs) are increased and associated with the disease activity in patients with axial spondyloarthritis (axSpA). However,…
  • Abstract Number: 0113 • ACR Convergence 2023

    Serum Myeloperoxidase (MPO)-DNA Complexes and Serum Calprotectin Differentiate Isolated Thrombotic Antiphospholipid Syndrome from Isolated Obstetric Antiphospholipid Syndrome

    Ruyu Liang1, Ranran Yao2, Ziye Wang3, Wenwen Pei2, Renge Liang3 and Chun Li4, 1Peking University, XiCheng, China, 2Peking University, Beijing, China, 3Peking University People's Hospital, Beijing, China, 4Peking University People’s Hospital, Beijing, China

    Background/Purpose: There is a lack of serum markers to differentiate thrombotic APS (tAPS) and obstetric APS (oAPS). Neutrophil extracellular traps (NETs) are involved in the…
  • Abstract Number: 2189 • ACR Convergence 2023

    Lymphopenia Fluctuation Patterns Determine the Trajectory of the Disease in Sjogren’s Patients with Hematological Involvement

    Giovanni Fulvio1, Matilde Bandeira2, Augusto Silva3, Gaetano La Rocca4, Silvia Fonzetti5, Francesco Ferro6, Marta Mosca7, Vasco Romão2, Chiara Baldini1, Manuel Silvério-António8 and Nikita Khmelinskii2, 1University of Pisa, Pisa, Italy, 2Centro Hospitalar Universitário Lisboa Norte, Lisboa, Portugal, 3Santa Maria Hospital, Maceira, Portugal, 4University of Pisa, Rheumatology Unit, Pisa, Italy, 5AOUP, Pisa, Italy, 6Clinical and Experimental Medicine Department, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy, 7Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy, 8Hospital Santa Maria, Lisboa, Portugal

    Background/Purpose: Sjogren's disease (SjD) is characterized by a moderate prevalence of cytopenia, mainly neutropenia and lymphocytopenia with a typical fluctuating pattern. The associations between clinical…
  • Abstract Number: 0259 • ACR Convergence 2023

    Preliminary Experience with a Novel “Fix” for Deep Epitope and Transcriptional Phenotyping of Fragile Cells from Autoinflammatory Flares

    Hallie Carol1, Emily Landy2 and Scott Canna1, 1Children's Hospital of Philadelphia, Philadelphia, PA, 2University of Pittsburgh, Pittsburgh, PA

    Background/Purpose: Autoinflammatory diseases (AID) are characterized by inflammation and immunopathology due to primary defects in the innate immune response. Neutrophils (PMN) feature prominently in the…
  • Abstract Number: 2233 • ACR Convergence 2023

    Neutrophil Levels Associate with Early Improvement in Spinal Pain and Week 24 Multi-Domain Disease Control During Guselkumab Treatment in Active Psoriatic Arthritis: Post Hoc Pooled Analyses of Two Phase 3 Randomized Controlled Trials

    Thomas Macleod1, Xenofon Baraliakos2, Emmanouil Rampakakis3, Warner Chen4, Antonius Pieter J Van Den Heuvel4, Loqmane Seridi4, May Shawi5, Frederic Lavie6, Joseph F. Merola7, Proton Rahman8 and Dennis McGonagle9, 1University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom, 2Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 3McGill University, Department of Pediatrics / JSS Medical Research, Scientific Affairs, Montreal, QC, Canada, 4Translational Sciences, Janssen Research & Development, LLC, Spring House, PA, 5Immunology, Janssen Research & Development, LLC, Titusville, NJ, 6The Janssen Pharmaceutical Companies of Johnson & Johnson, Paris, France, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA, 8Craig Dobbin Research Institute, Memorial University, St. John's, NL, Canada, 9Leeds Biomedical Research Centre, University of Leeds, Leeds, United Kingdom

    Background/Purpose: Neutrophils have potential pathogenic roles in chronic inflammatory diseases (e.g., neutrophilic cutaneous microabscesses in psoriasis, and neutrophils in the synovial fluid/tissue in PsA and…
  • Abstract Number: 0864 • ACR Convergence 2023

    Proteomic Analysis of Circulating Neutrophils from Osteoarthritis Patients Shows Metabolic Dysregulation That Is Associated with Decreased Physiologic Apoptosis

    Jennifer Amsler1, Morgane Le Gall2, Camille Daste3, François Rannou3 and Véronique Witko-Sarsat2, 1Institut Cochin, Bern, Switzerland, 2Institut Cochin, Paris, France, 3Hôpital Cochin, Paris, France

    Background/Purpose: Osteoarthritis (OA) has long been thought to be only of local mechanical origin. However, it has been shown recently that there is a phenotype…
  • Abstract Number: 2358 • ACR Convergence 2023

    Neutrophil Extracellular Traps Induce Endothelial-to-Mesenchymal Transition and Associate with Vascular Complications in Scleroderma

    Ramadan Ali1, Wenying Liang1, Claire Shiple1, Rosemary Gedert2, Suiyuan Huang1, Cyrus Sarosh1, Eliza Pei-Suen Tsou1, Dinesh Khanna1 and Jason Knight1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Onsted, MI

    Background/Purpose: Systemic sclerosis (SSc, also known as scleroderma) is a disease characterized by fibrosis, autoimmunity, and vasculopathy. Many devastating complications such as digital ulcerations, scleroderma…
  • Abstract Number: 079 • 2023 Pediatric Rheumatology Symposium

    Dynamics of Neutrophil Activation in Repeated TLR-9-Induced Mouse Model of Macrophage Activation Syndrome

    Natsumi Inoue, Richard Chhaing, Sanjeev Dhakal, Thuy Do and Grant Schulert, Cincinnati Children's Hospital Medical Center, Cincinnati, OH

    Background/Purpose: Macrophage activation syndrome (MAS) is a life-threatening complication of rheumatic diseases including systemic juvenile idiopathic arthritis (SJIA). SJIA shows prominent neutrophil activation with expansion…
  • Abstract Number: 130 • 2023 Pediatric Rheumatology Symposium

    Levels of Neutrophil Extracellular Traps Correlate with Disease Activity in Pediatric Lupus

    Lydia Thomas1, Jenna Battaglia2, Bharati Matta3, Kim Simpfendorfer4, Joyce Hui-Yuen5 and Betsy Barnes3, 1Cohen Children's Medical Center, Northwell Health, New Hyde Park, NY, 2Northwell Health, New York, NY, 3Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 4Robert S. Boas Center for Genomics and Human Genetics, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY, 5Cohen Children's Medical Center, Northwell Health, Lake Success, New York; Center for Autoimmune, Musculoskeletal, and Hematopoietic Diseases Research, Feinstein Institutes for Medical Research, Northwell Health, Manhasset, NY

    Background/Purpose: Pediatric lupus (pSLE) is a multisystemic autoimmune disease characterized by autoantibody production leading to organ damage. Neutrophil extracellular traps (NETs) are considered a potential…
  • Abstract Number: 0690 • ACR Convergence 2022

    The Physiological Ketone Body Beta-Hydroxybutyrate Potently Neutralizes APS-Associated NETosis

    Ajay Tambralli1, Alyssa Harbaugh1, Christine Rysenga1, Kaitlyn Sabb1, Srilakshmi Yalavarthi1, Claire Hoy1, Yu (Ray) Zuo1 and Jason S Knight2, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: Malleable metabolic pathways guide both productive and pathological neutrophil functions, including neutrophil extracellular trap release (NETosis). NETosis plays an important role in APS pathophysiology.…
  • Abstract Number: 2021 • ACR Convergence 2022

    Early Histopathological Changes of the Salivary Glands Associated with the Development of Primary Sjögren’s Syndrome

    Xiaomei Shan1, Clara Reichardt1, Jeeshan Singh1, Anne Zeitler2, Christine Schauer1, Jasmin Knopf1, Martin Herrmann1, Gerhard Grossmayer1, Georg Schett1 and Luis Munoz1, 1Universitätsklinikum Erlangen, Erlangen, Germany, 2Friedrich-Alexander University Erlangen Nürnberg, Erlangen, Germany

    Background/Purpose: Primary Sjögren's syndrome (PSS) is a chronic inflammatory disease affecting exocrine glands including salivary and lacrimal glands that leads to dry eyes and mouth…
  • Abstract Number: 0692 • ACR Convergence 2022

    The Interplay Between Lipid Peroxidation and Neutrophil Extracellular Trap (NET) Formation in APS Pathogenesis

    Naveen Kumar S K1, Claire Hoy1, Christine Rysenga1, Srilakshmi Yalavarthi1, Cyrus Sarosh2, Sherwin Navaz1, Jacqueline Madison1, Jason S Knight3 and Yu (Ray) Zuo1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Temperance, MI, 3University of Michigan, Division of Rheumatology, Ann Arbor, MI

    Background/Purpose: Lipid peroxidation is the result of disrupted redox homeostasis and functions as a key component in various cell death programs. Neutrophil extracellular trap (NET)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 10
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology